Bruker [BRKR] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Bruker Corporation

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bruker Corporation wins in 5 metrics, Abbott Laboratories wins in 15 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bruker Corporation Abbott Laboratories Better
P/E Ratio (TTM) 74.88 25.97 Abbott Laboratories
Price-to-Book Ratio 2.24 3.09 Bruker Corporation
Debt-to-Equity Ratio 81.38 26.79 Abbott Laboratories
PEG Ratio 6.74 -1.41 Bruker Corporation
EV/EBITDA 14.63 13.74 Abbott Laboratories
Profit Margin (TTM) -0.25% 13.90% Abbott Laboratories
Operating Margin (TTM) 6.58% 16.50% Abbott Laboratories
EBITDA Margin (TTM) 6.58% 16.50% Abbott Laboratories
Return on Equity -0.38% 12.36% Abbott Laboratories
Return on Assets (TTM) 2.90% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $13.90M $7.40B Abbott Laboratories
Dividend Yield 0.65% 1.97% Abbott Laboratories
1-Year Return 41.59% -34.98% Bruker Corporation
Price-to-Sales Ratio (TTM) 1.60 3.57 Bruker Corporation
Enterprise Value $7.31B $166.96B Abbott Laboratories
EV/Revenue Ratio 2.13 3.70 Bruker Corporation
Gross Profit Margin (TTM) 45.97% N/A N/A
Revenue per Share (TTM) $23 $26 Abbott Laboratories
Earnings per Share (Diluted) $-0.15 $3.57 Abbott Laboratories
Beta (Stock Volatility) 1.20 0.78 Abbott Laboratories
Short % of Float 17.68% 1.53% Abbott Laboratories

Bruker Corporation vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

BRKR
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bruker Corporation4.43%0.66%32.07%72.86%24.00%17.71%
Abbott Laboratories0.56%-2.02%4.97%-19.35%-30.98%-28.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bruker Corporation41.59%-28.15%-24.98%125.58%203.81%984.60%
Abbott Laboratories-34.98%-16.97%-20.08%135.84%255.56%329.52%

Performance & Financial Health Analysis: Bruker Corporation vs Abbott Laboratories

MetricBRKRABT
Market Information
Market Cap i$5.56B$160.70B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i2,049,28313,495,583
90 Day Avg. Volume i2,108,10812,934,461
Last Close$56.63$88.67
52 Week Range$28.53 - $64.54$81.97 - $139.06
% from 52W High-12.26%-36.24%
All-Time High$94.86 (Mar 18, 2024)$142.60 (Dec 27, 2021)
% from All-Time High-40.30%-37.82%
Growth Metrics
Quarterly Revenue Growth0.00%0.08%
Quarterly Earnings Growth0.90%-0.19%
Financial Health
Profit Margin (TTM) i0.00%0.14%
Operating Margin (TTM) i0.07%0.17%
Return on Equity (TTM) i0.00%0.12%
Debt to Equity (MRQ) i81.3826.79
Cash & Liquidity
Book Value per Share (MRQ)$16.15$30.02
Cash per Share (MRQ)$1.96$5.14
Operating Cash Flow (TTM) i$134.10M$10.80B
Levered Free Cash Flow (TTM) i$216.96M$13.77B
Dividends
Last 12-Month Dividend Yield i0.65%1.97%
Last 12-Month Dividend i$0.25$2.40

Valuation & Enterprise Metrics Analysis: Bruker Corporation vs Abbott Laboratories

MetricBRKR (Apr 26, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i74.8825.97
Forward P/E i15.0115.29
PEG Ratio i6.74-1.41
Price to Sales (TTM) i1.603.57
Price to Book (MRQ) i2.243.09
Market Capitalization
Market Capitalization i$5.56B$160.70B
Enterprise Value i$7.31B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i2.133.70
Enterprise to EBITDA i14.6313.74
Risk & Other Metrics
Beta i1.200.78
Book Value per Share (MRQ) i$16.15$30.02

Financial Statements Comparison: Bruker Corporation vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBRKR (2025)ABT (2025)
Revenue/Sales i3.44B44.33B
Cost of Goods Sold i1.86B19.32B
COGS % of Revenue i54.1%43.6%
Gross Profit i1.58B25.01B
Gross Margin i45.9%56.4%
Research & Development i395.20M2.94B
Operating Income (EBIT) i236.00M8.05B
Operating Margin i6.9%18.2%
EBITDA i456.80M12.03B
EBITDA Margin i13.3%27.1%
Pre-Tax Income i22.00M8.47B
Pre-Tax Income % of Revenue i0.6%19.1%
Income Tax i29.30M1.94B
Income Tax % of Revenue i0.9%4.4%
Net Income (Profit) i-8.30M6.52B
Profit Margin i-0.2%14.7%

Balance Sheet & Liquidity Metrics

MetricBRKR (2025)ABT (2025)
Cash & Equivalents i298.80M8.52B
Total Current Assets i2.21B26.00B
Total Current Assets % of Revenue i64.4%58.6%
Total Current Liabilities i1.28B16.50B
Total Current Liabilities % of Revenue i37.2%37.2%
Long-Term Debt i1.99B10.83B
Long-Term Debt % of Revenue i57.9%24.4%
Total Shareholders Equity i2.51B52.77B
Retained Earnings i2.36B49.78B
Retained Earnings % of Revenue i68.7%112.3%
Property, Plant & Equipment i165.80M17.57B

Cash Flow Statement Comparison

MetricBRKR (2025)ABT (2025)
Operating Cash Flow i82.50M10.80B
Operating Cash Flow % of Revenue i2.4%24.4%
Capital Expenditures i-90.80M-2.17B
Free Cash Flow i13.90M7.40B
FCF Margin i0.4%16.7%
Debt Repayment i-1.25B-1.50B
Common Stock Repurchase i-10.00M-893.00M

Short Interest & Institutional Ownership Analysis

MetricBRKRABT
Shares Short i12.53M23.83M
Short Ratio i6.301.93
Short % of Float i17.68%1.53%
Shares Outstanding i152.14M1.74B
Float Shares i103.57M1.73B
% Held by Insiders i26.95%0.54%
% Held by Institutions i91.32%82.23%
% Held by Public i-18.27%17.23%

Dividend Analysis & Yield Comparison: Bruker Corporation vs Abbott Laboratories

MetricBRKRABT
Last 12-Month Dividend i$0.25$2.40
Last 12-Month Dividend Yield i0.65%1.97%
3-Year Avg Annual Dividend i$0.20$2.24
3-Year Avg Dividend Yield i0.10%0.50%
3-Year Total Dividends i$0.60$6.72
Ex-Dividend DateMar 23, 2026Jan 15, 2026